经导管主动脉瓣植入术：老年及高危重度主动脉瓣狭窄患者治疗领域的一次变革。
Transcatheter aortic valve implantation: a revolution in the therapy of elderly and high-risk patients with severe aortic stenosis.
作者信息
Kilic Teoman, Yilmaz Irem
机构信息
Invasive Cardiology Research and Application Unit, Department of Cardiology, Kocaeli University, Kocaeli, Turkey.
Department of Cardiology, Kocaeli University, Kocaeli, Turkey.
出版信息
J Geriatr Cardiol. 2017 Mar;14(3):204-217. doi: 10.11909/j.issn.1671-5411.2017.03.002.
Abstract
Transcatheter aortic valve implantation (TAVI) represents a real revolution in the field of interventional cardiology for the treatment of elderly or high-risk surgical patients with severe symptomatic aortic valve stenosis. Today, TAVI seems to play a key and a reliable role in the treatment of intermediate and maybe low-risk patients with severe aortic stenosis. TAVI has also evolved from a complex and hazardous procedure into an effective and safe therapy by the development of new generation devices. This article aims to review the background and future of TAVI, clinical trials and registries with old and new generation TAVI devices and to focus on some open issues related to post-procedural outcomes.
摘要
经导管主动脉瓣植入术（TAVI）是介入心脏病学领域的一项重大变革，用于治疗有严重症状的主动脉瓣狭窄的老年或高风险外科手术患者。如今，TAVI似乎在治疗中度甚至可能是低风险的严重主动脉瓣狭窄患者中发挥着关键且可靠的作用。随着新一代设备的研发，TAVI也已从一项复杂且危险的手术演变为一种有效且安全的治疗方法。本文旨在回顾TAVI的背景与未来、使用新旧一代TAVI设备的临床试验和注册研究，并聚焦于一些与术后结果相关的未决问题。
相似文献
1
Transcatheter aortic valve implantation: a revolution in the therapy of elderly and high-risk patients with severe aortic stenosis.经导管主动脉瓣植入术：老年及高危重度主动脉瓣狭窄患者治疗领域的一次变革。
J Geriatr Cardiol. 2017 Mar;14(3):204-217. doi: 10.11909/j.issn.1671-5411.2017.03.002.
2
Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISE.经导管主动脉瓣植入术治疗严重主动脉瓣狭窄患者的更新临床适应证：意大利心脏病学会和 GISE 的专家意见。
J Cardiovasc Med (Hagerstown). 2018 May;19(5):197-210. doi: 10.2459/JCM.0000000000000636.
3
4
5
Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.经导管主动脉瓣植入术（TAVI）的极简方法：开放血管法与完全经皮法
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):5-14. doi: 10.2478/prilozi-2019-0009.
6
Transcatheter Aortic Valve Implantation for Severe Bicuspid Aortic Stenosis - 2 Years Follow up Experience From India.经导管主动脉瓣植入术治疗重度二叶式主动脉瓣狭窄——来自印度的2年随访经验
Front Cardiovasc Med. 2022 Jul 28;9:817705. doi: 10.3389/fcvm.2022.817705. eCollection 2022.
7
Transcatheter Aortic Valve Implantation Two Decades of Evolution - TAVI From Current Perspective.经导管主动脉瓣植入术：二十年的发展历程——从当前视角看经导管主动脉瓣置换术
Acta Inform Med. 2023;31(4):312-321. doi: 10.5455/aim.2023.31.312-321.
8
New Challenging Scenarios in Transcatheter Aortic Valve Implantation: Valve-in-valve, Bicuspid and Native Aortic Regurgitation.经导管主动脉瓣植入术的新挑战场景：瓣中瓣、二叶式主动脉瓣及主动脉瓣反流。
Eur Cardiol. 2021 Aug 26;16:e29. doi: 10.15420/ecr.2021.12. eCollection 2021 Feb.
9
Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment.中度手术风险的重度症状性主动脉瓣狭窄患者经导管主动脉瓣植入术：一项卫生技术评估
Ont Health Technol Assess Ser. 2020 Mar 6;20(2):1-121. eCollection 2020.
10
[Therapeutic revolution in the treatment of aortic stenosis : transcatheter aortic valve implantation (TAVI )].[主动脉瓣狭窄治疗的革命性进展：经导管主动脉瓣植入术（TAVI）]
Rev Med Liege. 2020 May;75(5-6):300-303.
引用本文的文献
1
Prevalence and predictors of permanent pacemaker implantation in patients with aortic stenosis undergoing transcatheter aortic valve implantation: a prospective cohort study.经导管主动脉瓣植入术治疗的主动脉瓣狭窄患者永久性起搏器植入的患病率及预测因素：一项前瞻性队列研究
BMJ Open. 2025 Feb 7;15(2):e093073. doi: 10.1136/bmjopen-2024-093073.
2
Early clinical and hemodynamic outcomes of balloon-expandable versus self-expanding transcatheter aortic valve replacement in patients with large aortic annulus: a study-level meta-analysis.大型主动脉瓣环患者行球囊扩张式与自膨式经导管主动脉瓣置换术的早期临床和血流动力学结果：一项研究水平的荟萃分析。
Indian J Thorac Cardiovasc Surg. 2024 Nov;40(6):696-706. doi: 10.1007/s12055-024-01770-1. Epub 2024 Jul 2.
3
Clinical outcomes of the Myval transcatheter heart valve system in patients with severe aortic valve stenosis: a two-year follow-up observational study.Myval经导管心脏瓣膜系统治疗严重主动脉瓣狭窄患者的临床结局：一项两年随访观察性研究
Arch Med Sci. 2024 Mar 4;20(2):410-419. doi: 10.5114/aoms/176937. eCollection 2024.
4
Prospective observational study on the accuracy of predictors of high-grade atrioventricular conduction block after transcatheter aortic valve implantation (CONDUCT-TAVI): study protocol, background and significance.经导管主动脉瓣植入术后预测高度房室传导阻滞准确性的前瞻性观察研究（CONDUCT-TAVI）：研究方案、背景和意义。
BMJ Open. 2023 Mar 8;13(3):e070219. doi: 10.1136/bmjopen-2022-070219.
5
Aortic root widening: "pro et contra".主动脉根部增宽：“支持与反对”
Indian J Thorac Cardiovasc Surg. 2022 Apr;38(Suppl 1):91-100. doi: 10.1007/s12055-020-01125-6. Epub 2021 Feb 22.
6
Aortography Keypoint Tracking for Transcatheter Aortic Valve Implantation Based on Multi-Task Learning.基于多任务学习的经导管主动脉瓣植入术中主动脉造影关键点跟踪
Front Cardiovasc Med. 2021 Jul 19;8:697737. doi: 10.3389/fcvm.2021.697737. eCollection 2021.
7
The value of screening for cognition, depression, and frailty in patients referred for TAVI.对接受 TAVI 治疗的患者进行认知、抑郁和衰弱筛查的价值。
Clin Interv Aging. 2019 May 8;14:841-848. doi: 10.2147/CIA.S201615. eCollection 2019.
8
Nanostim-leadless pacemaker.Nanostim无导线起搏器。
Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):327-333. doi: 10.1007/s00399-018-0598-3. Epub 2018 Oct 19.
本文引用的文献
1
Latest evidence on transcatheter aortic valve implantation vs. surgical aortic valve replacement for the treatment of aortic stenosis in high and intermediate-risk patients.经导管主动脉瓣植入术与外科主动脉瓣置换术治疗中高危主动脉瓣狭窄患者的最新证据。
Curr Opin Cardiol. 2017 Mar;32(2):117-122. doi: 10.1097/HCO.0000000000000379.
2
A systematic review on the safety of Prostar XL versus ProGlide after TAVR and EVAR.关于经导管主动脉瓣置换术（TAVR）和腔内修复术（EVAR）后Prostar XL与ProGlide安全性的系统评价。
Cardiovasc Revasc Med. 2017 Mar;18(2):145-150. doi: 10.1016/j.carrev.2016.11.004. Epub 2016 Nov 9.
3
Pushing the Limits in Transcatheter Aortic Valve Replacement: High-Volume Center's Effect, Overconfidence, or Something Else?经导管主动脉瓣置换术的极限挑战：高容量中心的影响、过度自信还是其他因素？
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2186-2188. doi: 10.1016/j.jcin.2016.08.014. Epub 2016 Oct 12.
4
Time to Explore Transcatheter Aortic Valve Replacement in Younger, Low-Risk Patients.探讨为年轻、低危患者行经导管主动脉瓣置换术的时机。
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2183-2185. doi: 10.1016/j.jcin.2016.08.015. Epub 2016 Oct 12.
5
Upcoming TAVI trials: rationale, design and impact on clinical practice.即将开展的经导管主动脉瓣植入术试验：基本原理、设计及其对临床实践的影响。
EuroIntervention. 2016 Sep 18;12(Y):Y51-5. doi: 10.4244/EIJV12SYA12.
6
Patient selection for TAVI in 2016: should we break through the low-risk barrier?2016年经导管主动脉瓣置入术的患者选择：我们应该突破低风险障碍吗？
EuroIntervention. 2016 Sep 18;12(Y):Y46-50. doi: 10.4244/EIJV12SYA11.
7
TAVI device selection: time for a patient-specific approach.经导管主动脉瓣植入术（TAVI）设备选择：采用个体化方法的时机。
EuroIntervention. 2016 Sep 18;12(Y):Y37-41. doi: 10.4244/EIJV12SYA9.
8
Late degeneration of transcatheter aortic valves: pathogenesis and management.经导管主动脉瓣的晚期退变：发病机制与管理
EuroIntervention. 2016 Sep 18;12(Y):Y33-6. doi: 10.4244/EIJV12SYA8.
9
Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing?经导管主动脉瓣植入术后瓣叶运动异常：是真正的威胁还是庸人自扰？
EuroIntervention. 2016 Sep 18;12(Y):Y28-32. doi: 10.4244/EIJV12SYA7.
10
TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery.使用当前获得CE认证的设备进行经导管主动脉瓣植入术：最佳尺寸选择和瓣膜输送策略。
EuroIntervention. 2016 Sep 18;12(Y):Y22-7. doi: 10.4244/EIJV12SYA6.
Zotero 插件